Cell State Transitions and Phenotypic Heterogeneity in Luminal Breast Cancer Implicating MicroRNAs as Potential Regulators

Luminal breast cancer subtypes respond poorly to endocrine and trastuzumab treatments due to cellular heterogeneity arising from the phenotype transitions, accounted for mainly by the loss of receptor expression. The origins of basal-like and human epidermal growth factor receptor 2 (HER2)-overexpre...

Descripción completa

Detalles Bibliográficos
Autores principales: Richard, Vinitha, Nair, Madhumathy G., Jaikumar, Vishnu S., Jones, Sara, Prabhu, Jyothi S., Kerin, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967449/
https://www.ncbi.nlm.nih.gov/pubmed/36834918
http://dx.doi.org/10.3390/ijms24043497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967449/
https://www.ncbi.nlm.nih.gov/pubmed/36834918
http://dx.doi.org/10.3390/ijms24043497

Ejemplares similares